Department of Neurology, Military Hospital, Rawalpindi, Pakistan.
Department of Neurology, Aga Khan University, Karachi, Pakistan.
Cerebrovasc Dis. 2019;48(3-6):184-192. doi: 10.1159/000504504. Epub 2019 Nov 27.
An association between cerebral venous sinus thrombosis (CVST) and high altitude has been previously proposed, but limited published data exist to support this association. We investigated 28 cases of CVST occurring at high altitude and sought to describe patient demographics, altitude and acclimatization, hematological laboratory findings, neuroimaging, treatment, and prognosis in these cases.
Twenty-eight cases of symptomatic CVST occurring at high altitude were identified between the months of August 2017 and December 2018, in collaboration with Military Hospital, Rawalpindi and Combined Military Hospital, Skardu (Pakistan). Follow-up visits were performed at 1 and 6 months.
Twenty-seven (96%) of the patients were males, and the mean age was 33 years. In total, 32.1% were smokers. The mean NIHSS score on presentation was 5.5. 85.7% of the cases occurred at altitude higher than 8,000 feet. On average 107.8 days were spent at a high altitude prior to CVST. Totally, 71.4% had acclimatized for >2 weeks. The mean hemoglobin (Hb) value was 16.7 g/dL and 50% had d-dimer levels higher than 1,000 ng/mL. On MRI, 25% showed signs of hemorrhage and 14.3% showed infarcts. Treatments provided include low-molecular-weight heparin and Rivaroxaban and were associated with good outcomes.
CVST is not uncommon at high altitude (>8,000 feet). It is predominantly a male disease. Most patients have high Hb and high D-dimer levels. The overall outcome was good.
先前曾提出脑静脉窦血栓形成(CVST)与高海拔之间存在关联,但有限的已发表数据支持这种关联。我们研究了 28 例发生在高海拔地区的 CVST,并试图描述这些病例的患者人口统计学特征、海拔和适应情况、血液学实验室检查结果、神经影像学表现、治疗和预后。
2017 年 8 月至 2018 年 12 月,与拉瓦尔品第军事医院和斯卡都联合军事医院(巴基斯坦)合作,确定了 28 例发生在高海拔地区的有症状 CVST 病例。在第 1 个月和第 6 个月进行随访。
27 例(96%)患者为男性,平均年龄为 33 岁。共有 32.1%的患者为吸烟者。入院时 NIHSS 平均评分为 5.5。85.7%的病例发生在海拔 8000 英尺以上的地方。在 CVST 发生之前,平均有 107.8 天处于高海拔地区。总共有 71.4%的人适应高海拔环境的时间超过 2 周。平均血红蛋白(Hb)值为 16.7g/dL,50%的患者 D-二聚体水平高于 1000ng/mL。磁共振成像(MRI)显示,25%的患者有出血迹象,14.3%的患者有梗死。提供的治疗方法包括低分子量肝素和利伐沙班,这些治疗方法与良好的结果相关。
CVST 在高海拔地区(>8000 英尺)并不罕见。它主要是一种男性疾病。大多数患者的 Hb 和 D-二聚体水平较高。总体预后良好。